Low interleukin-12 activity in severe Plasmodium falciparum malaria

Infection and Immunity

Volumn 68, Issue 7, 2000, Pages 3909-3915

  Luty, Adrian J F ^a   Perkins, Douglas J ^b,e   Lell, Bertrand ^a,c,d   Schmidt Ott, Ruprecht ^a,c   Lehman, Leopold G ^a,c   Luckner, Doris ^a,c   Greve, Bernhard ^a,c   Matousek, Peter ^c,d   Herbich, Klaus ^c,d   Schmid, Daniela ^c   Brice Weinberg, J ^b   Kremsner, Peter G ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c ALBERT SCHWEITZER HOSPITAL   (Gabon)

^d UNIVERSITY OF VIENNA   (Austria)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR;

ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MALARIA; NONHUMAN; PARASITEMIA; PHAGOCYTE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0033930109     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.7.3909-3915.2000     Document Type: Article

References (47)

1. Arese P., and E. Schwartzer. 1997. Malaria pigment (haemozoin): a very active 'inert' substance. Ann. Trop. Med. Parasitol. 91:501-516.
2. Brasseur, P., M. Agrapart, J. J. Ballet, P. Druilhe, M. J. Warrell, and S. Tharavanij. 1983. Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high parasitemia and cerebral malaria. Clin. Immunol. Immunopathol. 27:38-50.
3. Cassatella, M. A., L. Meda, S. Gasperini, A. D'Andrea, X. Ma, and G. Trinchieri. 1995. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25:1-5.
4. Crutcher, J. M., M. M. Stevenson, M. Sedegah, and S. L. Hoffman. 1995. Interleukin-12 and malaria. Res. Immunol. 146:552-559.
5. Grau, G. E., T. E. Taylor, M. E. Molyneux, J. J. Wirima, P. Vassalli, M. Hommel, and P.-H. Lambert. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586-1591.
6. Hayes, M. P., J. Wang, and M. A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646-650.
7. Ho, M., H. K. Webster, S. Looareesuwan, W. Supanaranond, R. E. Phillips, P. Chanthavanich, and D. A. Warrell. 1986. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J. Infect. Dis. 153:763-771.
8. Ho, M., M. Sexton, P. Tongtawe, S. Looareesuwan, P. Suntharasamai, and K. Webster. 1995. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific proliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172:838-844.
9. Ho, M., T. Schollardt, S. Snape, S. Looareesuwan, P. Suntharasamai, and N. J. White. 1998. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J. Infect. Dis. 178:520-525.
10. Hoffman, S., J. Crutcher, S. Puri, A. Ansari, F. Villinger, E. Franke, P. Singh, F. Finkelman, M. Gately, G. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med. 3:80-83.
11. Hviid, L., J. A. L. Kurtzhals, B. Q. Goka, J. O. Oliver-Commey, F. K. Nkrumah, and T. G. Theander. 1997. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect. Immun. 65:4090-4093.
12. Kern, P., C. J. Hemmer, J. Van Damme, H. J. Gruss, and M. Dietrich. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87:139-143.
13. Kremsner, P. G., G. M. Zotter, H. Feldmeier, W. Graninger, R. M. Rocha, and G. Wiedermann. 1988. A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. J. Infect. Dis. 158:1368-1371.
14. Kremsner, P. G., S. Winkler, C. Brandts, E. Wildling, L. Jenne, W. Graninger, J. Prada, U. Bienzle, P. Juillard, and G. E. Grau. 1995. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am. J. Trop. Med. Hyg. 53: 532-538.
15. Kun, J. F. J., R. J. Schmidt-Ott, L. G. Lehman, B. Lell, D. Luckner, B. Greve, P. Matousek, and P. G. Kremsner. 1998. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans. R. Soc. Trop. Med. Hyg. 92:110-114.
16. Kurtzhals, J. A. L., V. Adabayeri, B. Q. Goka, B. D. Akanmori, J. O. Oliver-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1998. Low plasma concentrations of interleukin 10 in severe malarial anemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772.
17. Kwiatkowski, D., A. V. S. Hill, I. Sambou, P. Twumasi, J. Castracane, K. R. Manogue, A. Cerami, D. R. Brewster, and B. M. Greenwood. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated malaria. Lancet 336:1201-1204.
18. Luckner, D., B. Lell, B. Greve, L. G. Lehman, R. J. Schmidt-Ott, P. Matousek, K. Herbich, D. Schmid, R. Mba, and P. G. Kremsner. 1998. No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. Trans. R. Soc. Trop. Med. Hyg. 92:478-481.
19. Luty, A. J. F., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, F. Migot-Nabias, P. Deloron, R. S. Nussenzweig, and P. G. Kremsner. 1999. Interferon-γ responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J. Infect. Dis. 179:980-988.
20. Metzger, W. G., B. G. Mordmüller, and P. G. Kremsner. 1995. Malaria pigment in leucocytes. Trans. R. Soc. Trop. Med. Hyg. 89:637-638.
21. Mohan, K., and M. Stevenson. 1998. Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J mice. Exp. Hematol. 26:45-52.
22. Mohan, K., H. Sam, and M. Stevenson. 1999. Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection. Infect. Immun. 67:513-519.
23. Mordmüller, B. G., W. G. Metzger, P. Juillard, B. M. N. Brinkman, C. L. Verweij, G. E. Grau, and P. G. Kremsner. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur. Cytokine Netw. 8:29-35.
24. Mordmüller, B. G., F. Turrini, H. Long, P. G. Kremsner, and P. Arese. 1998. Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production. Eur. Cytokine Netw. 9:239-246.
25. Mosmann, T., and R. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
26. Mosmann, T. R. 1991. Regulation of immune responses by T cells with different cytokine secretion phenotypes: role of a new cytokine, cytokine synthesis inhibitory factor (IL10). Int. Arch. Allergy Appl. Immunol. 94:110-115.
27. Mosser, D. M., and C. L. Karp. 1999. Receptor-mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11:406-411.
28. Mshana, R. N., J. Boulandi, N. M. Mshana, J. Mayombo, and G. Mendome. 1991. Cytokines in the pathogenesis of malaria: levels of IL-1β, IL-4, IL-6, TNF-α, and IFN-γ in plasma of healthy individuals and malaria patients in a holoendemic area. J. Clin. Lab. Immunol. 34:131-139.
29. Othoro, C., A. A. Lal, B. Nahlen, D. Koech, A. S. S. Orago, and V. Udhayakumar. 1999. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in West. Kenya. J. Infect. Dis. 179:279-282.
30. Perkins, D. J., P. G. Kremsner, D. Schmid, M. A. Misukonis, M. A. Kelly, and J. B. Weinberg. 1999. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect. Immun. 67:497-4981.
31. Phu, N. H., N. Day, P. T. Diep, D. J. P. Ferguson, and N. J. White. 1995. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 89:200-204.
32. Pichyangkul, S., P. Saengkrai, and H. K. Webster. 1994. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-α and interleukin-1β. Am. J. Trop. Med. Hyg. 51:430-435.
33. Prada, J., J. Malinowski, S. Muller, U. Bienzle, and P. G. Kremsner. 1995. Hemozoin differentially modulates the production of interleukin 6 and tumor necrosis factor in murine malaria. Eur. Cytokine Netw. 6:109-112.
34. Riley, E. M., G. Andersson, L. N. Otoo, S. Jepsen, and B. M. Greenwood. 1988. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin. Exp. Immunol. 73:17-22.
35. Sam, H., and M. M. Stevenson. 1999. In vivo IL-12 production and IL-12 receptors beta1 and beta2 mRNA expression in the spleen are differentially up-regulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi AS malaria. J. Immunol. 162:1582-1589.
36. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
37. Shaffer, N., G. E. Grau, K. Hedberg, F. Davachi, B. Lyamba, A. W. High-tower, J. G. Breman, and N. D. Phuc. 1991. Tumor necrosis factor and severe malaria. J. Infect. Dis. 163:96-101.
38. Sharara, A. I., D. J. Perkins, M. A. Misukonis, S. U. Chan, J. A. Dominitz, and J. B. Weinberg. 1997. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression - possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J. Exp. Med. 186:1495-1502.
39. Sherry, B. A., G. Alava, K. J. Tracey, J. Martiney, A. Cerami, and A. F. Slater. 1995. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-lalpha, and MIP-1beta) in vitro, and altered thermoregulation in vivo. J. Inflamm. 45:85-96.
40. Stevenson, M., and M. Tam. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin. Exp. Immunol. 92:77-83.
41. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
42. Storkus, W. J., H. Tahara, and M. T. Lotze. 1998. Interleukin-12, p. 391-25. In A. W. Thomson (ed.), The cytokine handbook, 3rd ed. Academic Press Inc., San Diego, Calif.
43. Trinchieri, G. 1993. IL-12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
44. Wildling, E., S. Winkler, P. G. Kremsner, C. Brandts, L. Jenne, and W. H. Wernsdorfer. 1995. Malaria epidemiology in the province of Moyen Ogooue, Gabon. Trop. Med. Parasitol. 46:77-82.
45. Winkler, S., M. Willheim, K. Baier, D. Schmid, A. Aichelburg, W. Graninger, and P. G. Kremsner. 1999. Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria. J. Infect. Dis. 179:209-216.
46. World Health Organization. 1997. World malaria situation in 1994. Weekly Epidemiol. Rec. 72:269-276.
47. Yoshimoto, T., T. Yoneto, S. Waki, and H. Nariuchi. 1998. Interleukin-12-dependent mechanisms in the clearance of blood-stage murine malaria parasite Plasmodium berghei XAT, an attenuated variant of P. berghei NK65. J. Infect. Dis. 177:1674-1681.